Can reduced intestinal absorption cause concurrent deficiencies in folate, vitamin D, zinc, selenium, and omega‑3 fatty acids?

Conditions that compromise the functional capacity of the small intestine, such as celiac disease and short bowel syndrome (SBS), severely impair nutrient bioavailability. This disruption typically results in a characteristic, multi-system pattern of micronutrient deficiencies that can affect patients across their lifespan, including middle-aged adults.

Pathophysiological mechanisms

• Mucosal enteropathy: Histological villus atrophy and mucosal flattening drastically reduce the functional surface area of the brush-border membrane.
• Impaired active transport: Folate, zinc, and selenium are primarily absorbed via specialized transport proteins in the duodenum and proximal jejunum (such as the proton-coupled folate transporter and ZIP4). Enterocyte damage directly disrupts these active transport pathways.
• Lipid malabsorption: Lipophilic nutrients, including vitamin D and essential omega-3 fatty acids (DHA and EPA), require effective emulsification and micelle formation. Extensive mucosal injury or bile acid wasting impedes these lipid pathways, preventing passive absorption into the lymphatic system.

Clinical evidence and presentation

• Overlapping deficiencies: In newly diagnosed celiac disease cohorts, biochemical deficiencies are highly prevalent even in the absence of classic diarrhea, with vitamin D deficiency occurring in 60% to 70% of patients, zinc deficiency in up to 40%, and folate deficiency in 30% to 40%.
• Trace element and lipid depletion: Patients with significant bowel resection (e.g., SBS with less than 200 cm of functional small bowel) consistently exhibit depleted selenium levels due to altered enterocyte transit, alongside biochemical evidence of essential fatty acid deficiency (indicated by elevated triene-to-tetraene ratios).

Bottom line

• Bottom line: Reduced intestinal absorption from mucosal damage or tissue loss causes a predictable pattern of concurrent deficiencies in folate, vitamin D, zinc, selenium, and omega-3 fatty acids, which requires systematic nutritional screening and targeted, high-dose replacement therapies to prevent long-term metabolic and immunological sequelae.